Live feed
Filing
SC 13D/A
SC 13D/A0001193125-20-008095·Akero Therapeutics, Inc.
Schedule 13D ownership disclosure
AKERO THERAPEUTICS INC
Security class unavailable · CUSIP: 00973Y108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-008095
- Form type
- SC 13D/A
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Jan 15, 2020
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership